[ACRX] QoQ Quarter Result on 31-Dec-2021 [#Q4]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
10-Mar-2022
Financial Year
2021
Quarter
31-Dec-2021 [#Q4]
Profit Trend
QoQ- 5.47%
YoY- 11.22%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Revenue 507 570 442 2 1,862 443 511 -0.52%
PBT -6,739 70,666 -8,674 -7,917 -8,375 -9,846 -8,956 -17.25%
Tax 11 3 -321 467 796 5 858 -94.50%
NP -6,750 70,663 -8,353 -7,917 -8,375 -9,851 -8,956 -17.16%
Tax Rate - -0.00% - - - - - -
Total Cost 7,257 -70,093 8,795 7,919 10,237 10,294 9,467 -16.22%
Ratio Analysis
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
NP Margin -1,331.36 12,397.02 -1,889.82 -395,850.00 -449.79 -2,223.70 -1,752.64 -16.73%
Per Share
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
EPS -0.91 9.60 -1.15 -1.24 -1.40 -1.65 -1.58 -30.75%
EPS Diluted -0.91 9.60 -1.15 -1.24 -1.40 -1.65 -1.58 -30.75%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.